TY  - GEN
AU  - Alvarez, Rocio
AU  - Lopez Cortes, Luis E
AU  - Molina, Jose
AU  - Cisneros, Jose M
AU  - Pachon, Jeronimo
PY  - 2016
DO  - 10.1128/AAC.03147-14
UR  - http://hdl.handle.net/10668/9819
T2  - Antimicrobial agents and chemotherapy
AB  - The increasing number of infections produced by beta-lactam-resistant Gram-positive bacteria and the morbidity secondary to these infections make it necessary to optimize the use of vancomycin. In 2009, the American Society of Health-System...
LA  - en
PB  - American Society for Microbiology
KW  - Beta-lactam-resistant bacteria
KW  - Vancomycin dosage
KW  - Pharmacokinetics
KW  - Serum concentration monitoring
KW  - Nephrotoxicity
KW  - Renal replacement therapy
KW  - Anti-Bacterial Agents
KW  - Drug Administration Schedule
KW  - Humans
KW  - Microbial Sensitivity Tests
KW  - Staphylococcus aureus
KW  - Vancomycin
TI  - Optimizing the Clinical Use of Vancomycin.
TY  - review
VL  - 60
ER  -